News

U.S. President Donald Trump signed an executive order this week to lower the cost of prescription drugs in the United States by requiring drug companies to match the lower prices found in other countr ...
Pfizer has said it will shed staff and cut its operating costs by around $ ... It has not provided any indication of the number of job losses. Around $4.2 billion of the correction will result ...
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
Real-time index price for TSX American Preferred Stock Index (STNC), along with buy or sell indicators, analysis, charts, historical performance, news and more ...
Retail giant Walmart is slashing around 1,500 corporate jobs after the company announced last week it plans to raise prices ...
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility ...
In an internal memo to staff on Friday, the central bank’s chair, Jerome H. Powell, said it would offer a voluntary deferred ...
Pfizer has asked the FDA for an emergency authorisation of the vaccine in the US and the US government expects to the first tranche to include about 6.4 million doses. In a separate announcement ...
Seven weeks into his job as FDA commissioner, Marty Makary, MD, MPH, held his own answering a barrage of sometimes ...
NewYork-Presbyterian Health reduced its workforce by 2%, or about 1,000 employees. Nurses voiced concerns that the layoffs unnecessarily harmed care.
Tourmaline Bio disclosed results for a potential rival to a Novo Nordisk drug. Elsewhere, data emerged for a psychedelic and CRISPR Therapeutics expanded its toolkit.